- Home
- INKT vs CALC Comparison
INKT vs CALC Comparison
Compare INKT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- CALC
- Stock Information
- Founded
- INKT 2017
- CALC 2011
- Country
- INKT United States
- CALC United States
- Employees
- INKT N/A
- CALC N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- INKT Health Care
- CALC Health Care
- Exchange
- INKT Nasdaq
- CALC Nasdaq
- Market Cap
- INKT 36.7M
- CALC 36.0M
- IPO Year
- INKT 2021
- CALC N/A
- Fundamental
- Price
- INKT $8.49
- CALC $1.98
- Analyst Decision
- INKT Strong Buy
- CALC Strong Buy
- Analyst Count
- INKT 2
- CALC 4
- Target Price
- INKT $19.50
- CALC $17.25
- AVG Volume (30 Days)
- INKT 9.9K
- CALC 32.6K
- Earning Date
- INKT 03-18-2025
- CALC 03-27-2025
- Dividend Yield
- INKT N/A
- CALC N/A
- EPS Growth
- INKT N/A
- CALC N/A
- EPS
- INKT N/A
- CALC N/A
- Revenue
- INKT N/A
- CALC N/A
- Revenue This Year
- INKT N/A
- CALC N/A
- Revenue Next Year
- INKT N/A
- CALC N/A
- P/E Ratio
- INKT N/A
- CALC N/A
- Revenue Growth
- INKT N/A
- CALC N/A
- 52 Week Low
- INKT $4.56
- CALC $1.83
- 52 Week High
- INKT $19.00
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- INKT 48.22
- CALC 34.66
- Support Level
- INKT $7.81
- CALC $1.83
- Resistance Level
- INKT $8.50
- CALC $2.28
- Average True Range (ATR)
- INKT 0.74
- CALC 0.23
- MACD
- INKT -0.12
- CALC -0.01
- Stochastic Oscillator
- INKT 29.66
- CALC 23.98
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.